[Advances in the study of glucokinase and small molecule glucokinase activators].
作者信息
Li Yong-Qiang, Feng Zhi-Qiang, Song Hong-Rui, Guo Yan-Sen, Guo Zong-Ru
机构信息
School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
出版信息
Yao Xue Xue Bao. 2006 May;41(5):390-4.
PMID:16848312
Abstract
摘要
相似文献
1
[Advances in the study of glucokinase and small molecule glucokinase activators].
Yao Xue Xue Bao. 2006 May;41(5):390-4.
2
Recent advances in glucokinase activators for the treatment of type 2 diabetes.
Drug Discov Today. 2009 Aug;14(15-16):784-92. doi: 10.1016/j.drudis.2009.05.013. Epub 2009 Jun 9.
3
Novel glucokinase activators: a patent review (2008 - 2010).
Expert Opin Ther Pat. 2011 Jan;21(1):13-33. doi: 10.1517/13543776.2011.542413. Epub 2010 Dec 15.
4
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
Bioorg Med Chem Lett. 2017 May 1;27(9):2069-2073. doi: 10.1016/j.bmcl.2016.10.085. Epub 2016 Oct 31.
5
Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus.
Bioorg Med Chem. 2014 Apr 1;22(7):2280-93. doi: 10.1016/j.bmc.2014.02.009. Epub 2014 Feb 17.
6
[Salicylic acid derivatives as simplified and novel GK small molecule activators].
Yao Xue Xue Bao. 2013 Apr;48(4):514-20.
7
Metabolic activation of N-thiazol-2-yl benzamide as glucokinase activators: Impacts of glutathione trapping on covalent binding.
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1619-22. doi: 10.1016/j.bmcl.2010.01.041. Epub 2010 Jan 20.
8
Design, synthesis and SAR of novel glucokinase activators.
Bioorg Med Chem Lett. 2013 Apr 1;23(7):2166-71. doi: 10.1016/j.bmcl.2013.01.093. Epub 2013 Feb 4.
9
Pharmacokinetic and pharmacodynamic properties of the glucokinase activator MK-0941 in rodent models of type 2 diabetes and healthy dogs.
Mol Pharmacol. 2011 Dec;80(6):1156-65. doi: 10.1124/mol.111.074401. Epub 2011 Sep 21.
10
SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides: discovery of PSN-GK1.
J Med Chem. 2008 Jul 24;51(14):4340-5. doi: 10.1021/jm8003202. Epub 2008 Jun 28.
Zotero 插件